Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.018 | 4.47872605126 | 0.4019 | 0.4209 | 0.371 | 361939 | 0.40557375 | CS |
| 4 | 0.0394 | 10.3547963206 | 0.3805 | 0.4234 | 0.3544 | 360179 | 0.38942361 | CS |
| 12 | -0.0611 | -12.7027027027 | 0.481 | 0.574 | 0.3421 | 619278 | 0.43037156 | CS |
| 26 | -0.022 | -4.97850192351 | 0.4419 | 0.608 | 0.3421 | 480748 | 0.45613736 | CS |
| 52 | -4.1601 | -90.8318777293 | 4.58 | 5.95 | 0.3421 | 701746 | 0.90299832 | CS |
| 156 | -1.7501 | -80.6497695853 | 2.17 | 5.95 | 0.3421 | 436297 | 1.57105837 | CS |
| 260 | -16.5801 | -97.53 | 17 | 35.6 | 0.3421 | 546768 | 3.21676715 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
